Skip to main content

Starboard Value has 1 million-share stake in Bristol-Myers Squibb, has met with management

Bristol-Myers Squibb confirms Starboard's stake in the company and says the $74 billion deal to acquire cancer drugmaker Celgene is "on track" to close during the third quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.